Xenon Pharmaceuticals XENE Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Xenon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The official record: Xenon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Xenon Pharmaceuticals's total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Xenon Pharmaceuticals's total liabilities?
- Xenon Pharmaceuticals (XENE) reported total liabilities of $48.99M in Q1 2026.
- How has Xenon Pharmaceuticals's total liabilities changed year-over-year?
- Xenon Pharmaceuticals's total liabilities increased by 24.6% year-over-year, from $39.32M to $48.99M.
- What is the long-term trend for Xenon Pharmaceuticals's total liabilities?
- Over 5 years (2020 to 2025), Xenon Pharmaceuticals's total liabilities has grown at a 23.6% compound annual growth rate (CAGR), from $17.83M to $51.4M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.